Filing Details
- Accession Number:
- 0001235802-23-000071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-26 16:26:41
- Reporting Period:
- 2023-06-23
- Accepted Time:
- 2023-06-26 16:26:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401040 | Diamedica Therapeutics Inc. | DMAC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1872863 | Pauling Charles Semba | 301 Carlson Parkway, Suite 210 Minneapolis MN 55305 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Shares, No Par Value Per Share | Acquisiton | 2023-06-23 | 12,787 | $3.91 | 29,943 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 12,867 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.
Billionaire Hedge Funds
